Morgan Stanley Bullish on Medtech in 2025, Upgrades 5 Stocks
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Globus Medical Raised to Overweight From Equal-Weight by Morgan Stanley
Globus Medical Analyst Ratings
Morgan Stanley Initiates Globus Medical(GMED.US) With Buy Rating, Announces Target Price $100
3 Reasons Why Growth Investors Shouldn't Overlook Globus Medical (GMED)
Globus Medical, Inc. (NYSE:GMED) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Globus Medical(GMED.US) Director Sells US$3.4 Million in Common Stock
Globus Medical(GMED.US) Officer Sells US$11.05 Million in Common Stock
Globus Medical Insider Sold Shares Worth $11,050,000, According to a Recent SEC Filing
Insider Sale: President of $GMED (GMED) Sells 130,000 Shares
GMED Stock Might Rise From the Commercial Launch of Its ExcelsiusHub
Globus Medical Launches ExcelsiusHub Navigation System
PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US
Express News | Form 144 | Globus Medical(GMED.US) Officer Proposes to Sell 11.04 Million in Common Stocks
These 19 Stocks Are Poised for Tax Reform Turbocharge - Jefferies
Patterson Companies Stock Up Following Latest Partnership Extension
Here's Why You Should Add OMCL Stock to Your Portfolio Now
JMP Securities Maintains Globus Medical(GMED.US) With Hold Rating
Globus Medical's Strong Q3 Performance and Conservative Outlook Justify Hold Rating Amid Merger Challenges